Long-Acting Injectable Cabotegravir plus Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR Trials

Authors
Publication date
1 December 2020
Publisher
'Ovid Technologies (Wolters Kluwer Health)'
Doi

    Abstract

    Abstract is not available.

      Similar works

      Full text

      thumbnail-image

      Available Versions

      Supporting member

      Queen Mary Research Online

      redirect
      oaioai:qmro.qmul.ac.uk:123456789/...
      Last time updated on 07/04/2021